Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease.
Journal of the American Heart Association（2016）
摘要
URL: https://www.clinicaltrials.gov. Unique identifier: NCT00799903.
更多查看译文
关键词
atherosclerosis,coronary disease,inflammation,lipoprotein,myocardial infarction
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要